Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Travis T Sims

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
American Journal of Clinical Oncology|May 22, 2018
The Significance of Para-Aortic Nodal Size and the Role of Adjuvant Systemic Chemotherapy in Cervical Cancer: An Institutional ExperienceDustin B Manders, Travis T Sims, April Bailey, et al.
Gynecologic Oncology|September 11, 2019
Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controlsTravis T Sims, Lauren E Colbert, Jiali Zheng, et al.
Gynecologic Oncology|December 8, 2019
Incorporation of whole pelvic radiation into treatment of stage IVB cervical cancer: A novel treatment strategyVictoria Perkins, Kathleen Moore, Sara Vesely, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 22, 2023
Characterizing morphologic subtypes of high-grade serous ovarian cancer by CT: a retrospective cohort studyKatherine I Foster, Katelyn F Handley, Deanna Glassman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 8, 2026
Oral cyclophosphamide combined with bevacizumab in recurrent heavily pre-treated ovarian cancerMostafa F Eyada, Victoria Michael, Shrina Patel, et al.
JCO Global Oncology|October 29, 2025
Cervical and Tumor-Associated Microbiomes in Botswana Women With and Without HIV With Carcinoma of the Cervix Before and After Definitive ChemoradiationTravis T Sims, Kyoko Yoshida-Court, Molly B El Alam, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 16, 2024
The association of the chemotherapy response score and homologous recombination deficiency in patients undergoing interval tumor reductive surgery following neoadjuvant chemotherapyRoni Nitecki Wilke, Jinsong Liu, Shannon Neville Westin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 18, 2020
Tumor microbial diversity and compositional differences among women in Botswana with high-grade cervical dysplasia and cervical cancerTravis T Sims, Greyson W G Biegert, Doreen Ramogola-Masire, et al.
Journal of Microbiological Methods|March 31, 2021
Diversity and composition of gut microbiome of cervical cancer patients: Do results of 16S rRNA sequencing and whole genome sequencing approaches align?Greyson Biegert, Molly B El Alam, Tatiana Karpinets, et al.
Plos One|January 6, 2023
Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancerKyoko Yoshida-Court, Tatiana V Karpinets, Aparna Mitra, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
American Journal of Clinical Oncology|May 22, 2018
The Significance of Para-Aortic Nodal Size and the Role of Adjuvant Systemic Chemotherapy in Cervical Cancer: An Institutional ExperienceDustin B Manders, Travis T Sims, April Bailey, et al.
Gynecologic Oncology|September 11, 2019
Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controlsTravis T Sims, Lauren E Colbert, Jiali Zheng, et al.
Gynecologic Oncology|December 8, 2019
Incorporation of whole pelvic radiation into treatment of stage IVB cervical cancer: A novel treatment strategyVictoria Perkins, Kathleen Moore, Sara Vesely, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 22, 2023
Characterizing morphologic subtypes of high-grade serous ovarian cancer by CT: a retrospective cohort studyKatherine I Foster, Katelyn F Handley, Deanna Glassman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 8, 2026
Oral cyclophosphamide combined with bevacizumab in recurrent heavily pre-treated ovarian cancerMostafa F Eyada, Victoria Michael, Shrina Patel, et al.
JCO Global Oncology|October 29, 2025
Cervical and Tumor-Associated Microbiomes in Botswana Women With and Without HIV With Carcinoma of the Cervix Before and After Definitive ChemoradiationTravis T Sims, Kyoko Yoshida-Court, Molly B El Alam, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 16, 2024
The association of the chemotherapy response score and homologous recombination deficiency in patients undergoing interval tumor reductive surgery following neoadjuvant chemotherapyRoni Nitecki Wilke, Jinsong Liu, Shannon Neville Westin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 18, 2020
Tumor microbial diversity and compositional differences among women in Botswana with high-grade cervical dysplasia and cervical cancerTravis T Sims, Greyson W G Biegert, Doreen Ramogola-Masire, et al.
Journal of Microbiological Methods|March 31, 2021
Diversity and composition of gut microbiome of cervical cancer patients: Do results of 16S rRNA sequencing and whole genome sequencing approaches align?Greyson Biegert, Molly B El Alam, Tatiana Karpinets, et al.
Plos One|January 6, 2023
Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancerKyoko Yoshida-Court, Tatiana V Karpinets, Aparna Mitra, et al.
Pageof 4